Download PDF
J Pediatr Infect Dis 2016; 11(03): 99-105
DOI: 10.1055/s-0036-1597302
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Infection in Hemodialysis

Raj Munshi
1   Division of Nephrology, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington, United States
› Author Affiliations
Further Information

Publication History

30 July 2016

16 September 2016

Publication Date:
12 December 2016 (online)

    Permissions and Reprints

Abstract

Infectious complications are a major cause of morbidity and mortality among pediatric patients undergoing dialysis. Hemodialysis is the most common modality for initiation of dialysis. Risk of infections in the hemodialysis population is related to increased exposure to health care environment, lapses in infectious control practices, requirement of central venous access, and an immunocompromised state. Here, we review risk factors toward infection, strategies for prevention, and approach to therapy in the pediatric hemodialysis population.

Keywords

hemodialysis - catheter-related blood stream infections - infection
 

  • References

  • 1 System USRD. 2015 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015
    Google Scholar
  • 2 Hörl WH. Neutrophil function and infections in uremia. Am J Kidney Dis 1999; 33 (02) xlv-xlviii
    PubMedGoogle Scholar
  • 3 Hörl WH, Haag-Weber M, Georgopoulos A, Block LH. Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci U S A 1990; 87 (16) 6353-6357
    CrossrefPubMedGoogle Scholar
  • 4 Hörl WH, Haag-Weber M, Mai B, Massry SG. Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients. Kidney Int 1995; 47 (06) 1741-1745
    CrossrefPubMedGoogle Scholar
  • 5 Patruta SI, Edlinger R, Sunder-Plassmann G, Hörl WH. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 1998; 9 (04) 655-663
    PubMedGoogle Scholar
  • 6 Tschesche H, Kopp C, Hörl WH, Hempelmann U. Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment. J Biol Chem 1994; 269 (48) 30274-30280
    PubMedGoogle Scholar
  • 7 Nguyen DB, Gutowski J, Ghiselli M. , et al. A large outbreak of hepatitis C virus infections in a hemodialysis clinic. Infect Control Hosp Epidemiol 2016; 37 (02) 125-133
    CrossrefPubMedGoogle Scholar
  • 8 Patel PR, Thompson ND, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis 2010; 56 (02) 371-378
    CrossrefPubMedGoogle Scholar
  • 9 Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993; 22 (04) 568-573
    CrossrefPubMedGoogle Scholar
  • 10 Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990; 112 (12) 958-960
    CrossrefPubMedGoogle Scholar
  • 11 Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38 (01) 44-48
    PubMedGoogle Scholar
  • 12 Jonas MM, Zilleruelo GE, LaRue SI, Abitbol C, Strauss J, Lu Y. Hepatitis C infection in a pediatric dialysis population. Pediatrics 1992; 89 4 Pt 2 707-709
    PubMedGoogle Scholar
  • 13 Shah SR, Khan MS, Alam MT, Salim A, Hussain M, Altaf A. End stage renal disease: seroprevalence of hepatitises B and C along with associated aetiology and risk factors in children. J Trop Med 2015; 2015: 936094
    PubMedGoogle Scholar
  • 14 Molle ZL, Baqi N, Gretch D, Hidalgo G, Tejani A, Rabinowitz SS. Hepatitis C infection in children and adolescents with end-stage renal disease. Pediatr Nephrol 2002; 17 (06) 444-449
    CrossrefPubMedGoogle Scholar
  • 15 Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001; 50 ( RR-05) 1-43
    PubMedGoogle Scholar
  • 16 Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18 (01) 52-61
    CrossrefPubMedGoogle Scholar
  • 17 CDC urging dialysis providers and facilities to assess and improve infection control practices to stop hepatitis C virus transmission in patients undergoing hemodialysis. Am J Transplant 2016; 16 (05) 1633-1634
    CrossrefPubMedGoogle Scholar
  • 18 Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1 8219 550-551
    PubMedGoogle Scholar
  • 19 Favero MS, Maynard JE, Petersen NJ. , et al. Letter: hepatitis-B antigen on environmental surfaces. Lancet 1973; 2 7843 1455
    PubMedGoogle Scholar
  • 20 Alter HJ, Seeff LB, Kaplan PM. , et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 1976; 295 (17) 909-913
    CrossrefPubMedGoogle Scholar
  • 21 Shikata T, Karasawa T, Abe K. , et al. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977; 136 (04) 571-576
    CrossrefPubMedGoogle Scholar
  • 22 CDC. Hepatitis: Control Measures for Hepatitis B in Dialysis Centers. HEW publication no. (CDC) 78–8358 (Viral Hepatitis Investigations and Control Series). Atlanta, GA: US Department of Health, Education and Welfare, Public Health Services; 1977. . Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients. MMWR Recommend Rep 2001;50(RR05):1–43
    Google Scholar
  • 23 Zwolińska D, Inglot M, Makulska I. , et al. Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis [in Polish]. Pol Merkuriusz Lek 2001; 10 (58) 267-270
    PubMedGoogle Scholar
  • 24 Rhea S, Moorman A, Pace R. , et al. Hepatitis B reverse seroconversion and transmission in a hemodialysis center: a public health investigation and case report. Am J Kidney Dis 2016; 68 (02) 292-295
    CrossrefPubMedGoogle Scholar
  • 25 Rouphael NG, Talati NJ, Rimland D. Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature. AIDS 2007; 21 (06) 771-774
    CrossrefPubMedGoogle Scholar
  • 26 Marcellin P, Giostra E, Martinot-Peignoux M. , et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100 5 Pt 1 1432-1434
    CrossrefPubMedGoogle Scholar
  • 27 Roberts RC, Lane C, Hatfield P. , et al. All anti-HBc-positive, HBsAg-negative dialysis patients on the transplant waiting list should be regarded as at risk of hepatitis B reactivation post-renal transplantation--report of three cases from a single centre. Nephrol Dial Transplant 2006; 21 (11) 3316-3319
    CrossrefPubMedGoogle Scholar
  • 28 Mashragi F, Bernstein RS, Al-Mazroa M. , et al. HIV transmission at a Saudi Arabia hemodialysis unit. Clin Infect Dis 2014; 59 (06) 897-902
    CrossrefPubMedGoogle Scholar
  • 29 Velandia M, Fridkin SK, Cárdenas V. , et al. Transmission of HIV in dialysis centre. Lancet 1995; 345 8962 1417-1422
    CrossrefPubMedGoogle Scholar
  • 30 Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60 (08) 243-248
    PubMedGoogle Scholar
  • 31 Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993; 64 (01) 95-100
    CrossrefPubMedGoogle Scholar
  • 32 Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9 (05) 869-876
    PubMedGoogle Scholar
  • 33 Sucupira C, Abramczyk ML, de Abreu Carvalhaes JT, de Moraes-Pinto MI. Surveillance system of hemodialysis-associated infections in a pediatric unit. Infect Control Hosp Epidemiol 2012; 33 (05) 521-523
    CrossrefPubMedGoogle Scholar
  • 34 Hayes WN, Watson AR, Callaghan N, Wright E, Stefanidis CJ. ; European Pediatric Dialysis Working Group. Vascular access: choice and complications in European paediatric haemodialysis units. Pediatr Nephrol 2012; 27 (06) 999-1004
    CrossrefPubMedGoogle Scholar
  • 35 Chand DH, Valentini RP. International pediatric fistula first initiative: a call to action. Am J Kidney Dis 2008; 51 (06) 1016-1024
    CrossrefPubMedGoogle Scholar
  • 36 Silva Jr MB, Hobson II RW, Pappas PJ. , et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27 (02) 302-307 , discussion 307–308
    CrossrefPubMedGoogle Scholar
  • 37 Scientific Registry of Transplant Recipients. 2014 . Available at: http://srtr.transplant.hrsa.gov/annual_reports/2012/pdf/01_kidney_13.pdf . Accessed July 29, 2016
    PubMed
  • 38 Soi V, Moore CL, Kumbar L, Yee J. Prevention of catheter-related bloodstream infections in patients on hemodialysis: challenges and management strategies. Int J Nephrol Renovasc Dis 2016; 9: 95-103
    PubMedGoogle Scholar
  • 39 Lata C, Girard L, Parkins M, James MT. Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review. Can J Kidney Health Dis 2016; 3: 24
    CrossrefPubMedGoogle Scholar
  • 40 Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck MA, Horan TC. NHSN Participants in Outpatient Dialysis Surveillance. Dialysis surveillance report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial 2008; 21 (01) 24-28
    PubMedGoogle Scholar
  • 41 Sychev D, Maya ID, Allon M. Clinical outcomes of dialysis catheter-related candidemia in hemodialysis patients. Clin J Am Soc Nephrol 2009; 4 (06) 1102-1105
    CrossrefPubMedGoogle Scholar
  • 42 Oliveira L, Graham J, Lok C, MacFarlane S, Zimmerman D. Risk factors for yeast superinfection in the treatment of suspected exit site infections: a case-control study. J Vasc Access 2008; 9 (01) 35-38
    CrossrefPubMedGoogle Scholar
  • 43 (AAMI) AftAoMI. Dialysate for Hemodialysis (ANSI/AAMI 13959:2014). Arlington, VA: American National Standard; 2014
    Google Scholar
  • 44 Levin R. The role of water in dialysis: why does it need to be more than “clean”?. Nephrol News Issues 2001; 15 (02) 21-23
    PubMedGoogle Scholar
  • 45 (AAMI) AftAoMI. Dialysate for Hemodialysis (ANSA/AAMI RD52:2004). Arlington, VA: American National Standard; 2004
    Google Scholar
  • 46 Hasegawa T, Nakai S, Masakane I. , et al. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Am J Kidney Dis 2015; 65 (06) 899-904
    CrossrefPubMedGoogle Scholar
  • 47 Ouseph R, Ward RA. Ultrapure dialysate for home hemodialysis?. Adv Chronic Kidney Dis 2007; 14 (03) 256-262
    CrossrefPubMedGoogle Scholar
  • 48 Favero M, Tokars J, Arduino M, Alter M. Nosocomial infections associated with hemodialysis. In: Mayhall C. , ed. Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999: 897-917
    Google Scholar
  • 49 Centers for Disease Control and Prevention (CDC). Outbreaks of gram-negative bacterial bloodstream infections traced to probable contamination of hemodialysis machines--Canada, 1995; United States, 1997; and Israel, 1997. MMWR Morb Mortal Wkly Rep 1998; 47 (03) 55-59
    PubMedGoogle Scholar
  • 50 Tokars J, Alter M, Arduino M. Nosocomial infections in the hemodialysis units: strategies for control. In: Owen W, Pereira B, Sayegh M. , eds. Dialysis and transplantation: a Companion to Brener and Rector's The Kidney. Philadelphia, PA: W.B. Saunders Company; 2000: 337-357
    Google Scholar
  • 51 von Eiff C, Becker K, Machka K, Stammer H, Peters G. ; Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344 (01) 11-16
    CrossrefPubMedGoogle Scholar
  • 52 Lu PL, Tsai JC, Chiu YW. , et al. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 2008; 23 (05) 1659-1665
    CrossrefPubMedGoogle Scholar
  • 53 Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol 1996; 17 (01) 47-52
    CrossrefPubMedGoogle Scholar
  • 54 Grothe C, Taminato M, Belasco A, Sesso R, Barbosa D. Screening and treatment for Staphylococcus aureus in patients undergoing hemodialysis: a systematic review and meta-analysis. BMC Nephrol 2014; 15: 202
    CrossrefPubMedGoogle Scholar
  • 55 Schmid H, Romanos A, Schiffl H, Lederer SR. Persistent nasal methicillin-resistant Staphylococcus aureus carriage in hemodialysis outpatients: a predictor of worse outcome. BMC Nephrol 2013; 14: 93
    CrossrefPubMedGoogle Scholar
  • 56 van Loon MM, Goovaerts T, Kessels AG, van der Sande FM, Tordoir JH. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant 2010; 25 (01) 225-230
    CrossrefPubMedGoogle Scholar
  • 57 Collier S, Kandil H, Yewnetu E, Cross J, Caplin B, Davenport A. Infection rates following buttonhole cannulation in hemodialysis patients. Ther Apher Dial 2016; 20 (05) 476-482
    CrossrefPubMedGoogle Scholar
  • 58 Muir CA, Kotwal SS, Hawley CM. , et al. Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review. Clin J Am Soc Nephrol 2014; 9 (01) 110-119
    CrossrefPubMedGoogle Scholar
  • 59 Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19 (03) 670-677
    CrossrefPubMedGoogle Scholar
  • 60 Weijmer MC, Vervloet MG, ter Wee PM. Prospective follow-up of a novel design haemodialysis catheter; lower infection rates and improved survival. Nephrol Dial Transplant 2008; 23 (03) 977-983
    PubMedGoogle Scholar
  • 61 Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168 (02) 400-407
    CrossrefPubMedGoogle Scholar
  • 62 Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21 (08) 2247-2255
    CrossrefPubMedGoogle Scholar
  • 63 Zhao Y, Li Z, Zhang L. , et al. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 2014; 63 (03) 479-490
    CrossrefPubMedGoogle Scholar
  • 64 Punt CD, Boer WE. Cardiac arrest following injection of concentrated trisodium citrate. Clin Nephrol 2008; 69 (04) 317-318
    CrossrefPubMedGoogle Scholar
  • 65 Hemmelgarn BR, Moist LM, Lok CE. , et al; Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin Study Group. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011; 364 (04) 303-312
    CrossrefPubMedGoogle Scholar
  • 66 Manns BJ, Scott-Douglas N, Tonelli M. , et al. An economic evaluation of rt-PA locking solution in dialysis catheters. J Am Soc Nephrol 2014; 25 (12) 2887-2895
    CrossrefPubMedGoogle Scholar
  • 67 O'Grady NP, Alexander M, Burns LA. , et al; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52 (09) e162-e193
    CrossrefPubMedGoogle Scholar
  • 68 Centers for Disease Control and Prevention (CDC). Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999. MMWR Morb Mortal Wkly Rep 2000; 48 51-52 1165-1167
    PubMedGoogle Scholar
  • 69 Mermel LA, Allon M, Bouza E. , et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49 (01) 1-45
    CrossrefPubMedGoogle Scholar
  • 70 Fogel MA, Nussbaum PB, Feintzeig ID, Hunt WA, Gavin JP, Kim RC. Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. Am J Kidney Dis 1998; 32 (03) 401-409
    CrossrefPubMedGoogle Scholar
  • 71 Chan KE, Warren HS, Thadhani RI. , et al. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc Nephrol 2012; 23 (09) 1551-1559
    CrossrefPubMedGoogle Scholar
  • 72 Stryjewski ME, Szczech LA, Benjamin Jr DK. , et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44 (02) 190-196
    CrossrefPubMedGoogle Scholar
  • 73 Group HAW. ; Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48 (Suppl. 01) S2-S90
    CrossrefPubMedGoogle Scholar
  • 74 Vanholder R, Canaud B, Fluck R. , et al. Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant 2010; 25 (06) 1753-1756
    CrossrefPubMedGoogle Scholar
  • 75 Aslam S, Vaida F, Ritter M, Mehta RL. Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia. J Am Soc Nephrol 2014; 25 (12) 2927-2941
    CrossrefPubMedGoogle Scholar
  • 76 Patel PR, Yi SH, Booth S. , et al. Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report. Am J Kidney Dis 2013; 62 (02) 322-330
    CrossrefPubMedGoogle Scholar
  • 77 CDC. Reducing bloodstream infections in an outpatient hemodialysis center--New Jersey, 2008-2011. MMWR Morb Mortal Wkly Rep 2012; 61 (10) 169-173 . PMID: 22419049
    PubMedGoogle Scholar